» Articles » PMID: 26454828

Multiplexed Detection of Influenza A Virus Subtype H5 and H9 Via Quantum Dot-based Immunoassay

Overview
Date 2015 Oct 12
PMID 26454828
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

A quantum dot-based lateral flow immunoassay system (QD-LFIAS) was developed to simultaneously detect both influenza A virus subtypes H5 and H9. Water-soluble carboxyl-functionalized quantum dots (QDs) were used as fluorescent tags. The QDs were conjugated to specific influenza A virus subtype H5 and H9 antibodies via an amide bond. When influenza A virus subtype H5 or H9 was added to the QD-LFIAS, the QD-labeled antibodies specifically bound to the H5 or H9 subtype viruses and were then captured by the coating antibodies at test line 1 or 2 to form a sandwich complex. This complex produced a bright fluorescent band in response to 365 nm ultraviolet excitation. The intensity of fluorescence can be detected using an inexpensive, low-maintenance instrument, and the virus concentration directly correlates with the fluorescence intensity. The detection limit of the QD-LFIAS for influenza A virus subtype H5 was 0.016 HAU, and the detection limit of the QD-LFIAS for influenza A virus subtype H9 was 0.25 HAU. The specificity and reproducibility were good. The simple analysis step and objective results that can be obtained within 15 min indicate that this QD-LFIAS is a highly efficient test that can be used to monitor and prevent both Influenza A virus subtypes H5 and H9.

Citing Articles

Development of a graphene oxide multilayer quantum dot-based immunochromatographic strip for the ultrasensitive detection of H7 subtype avian influenza viruses.

Fu J, Wang P, Wu H, Yang F, Cheng L, Liu F Poult Sci. 2025; 104(4):104924.

PMID: 39985899 PMC: 11904543. DOI: 10.1016/j.psj.2025.104924.


Recent Advances in Quantum Dot-Based Lateral Flow Immunoassays for the Rapid, Point-of-Care Diagnosis of COVID-19.

Mousavi S, Kalashgrani M, Gholami A, Omidifar N, Binazadeh M, Chiang W Biosensors (Basel). 2023; 13(8).

PMID: 37622872 PMC: 10452855. DOI: 10.3390/bios13080786.


Recent Trends in Lateral Flow Immunoassays with Optical Nanoparticles.

Kim J, Shin M, Shin J, Kim H, Pham X, Park S Int J Mol Sci. 2023; 24(11).

PMID: 37298550 PMC: 10253776. DOI: 10.3390/ijms24119600.


Nanotechnology-Enabled Biosensors: A Review of Fundamentals, Design Principles, Materials, and Applications.

Ramesh M, Janani R, Deepa C, Rajeshkumar L Biosensors (Basel). 2023; 13(1).

PMID: 36671875 PMC: 9856107. DOI: 10.3390/bios13010040.


Quantum Dot-Based Lateral Flow Immunoassay as Point-of-Care Testing for Infectious Diseases: A Narrative Review of Its Principle and Performance.

Ahmad Najib M, Selvam K, Khalid M, Ozsoz M, Aziah I Diagnostics (Basel). 2022; 12(9).

PMID: 36140559 PMC: 9497919. DOI: 10.3390/diagnostics12092158.


References
1.
Yang S, Chieh J, Wang W, Yu C, Lan C, Chen J . Ultra-highly sensitive and wash-free bio-detection of H5N1 virus by immunomagnetic reduction assays. J Virol Methods. 2008; 153(2):250-2. DOI: 10.1016/j.jviromet.2008.07.025. View

2.
Yuan Z, Zhu W, Chen Y, Zhou P, Cao Z, Xie J . Serological surveillance of H5 and H9 avian influenza A viral infections among pigs in Southern China. Microb Pathog. 2013; 64:39-42. DOI: 10.1016/j.micpath.2013.08.001. View

3.
Xie Z, Pang Y, Liu J, Deng X, Tang X, Sun J . A multiplex RT-PCR for detection of type A influenza virus and differentiation of avian H5, H7, and H9 hemagglutinin subtypes. Mol Cell Probes. 2006; 20(3-4):245-9. DOI: 10.1016/j.mcp.2006.01.003. View

4.
Xiong W, Yang G, Wu X, Zhu J . Aqueous synthesis of color-tunable CuInS2/ZnS nanocrystals for the detection of human interleukin 6. ACS Appl Mater Interfaces. 2013; 5(16):8210-6. DOI: 10.1021/am402328t. View

5.
Grabowska I, Stachyra A, Gora-Sochacka A, Sirko A, Olejniczak A, Lesnikowski Z . DNA probe modified with 3-iron bis(dicarbollide) for electrochemical determination of DNA sequence of Avian Influenza Virus H5N1. Biosens Bioelectron. 2013; 51:170-6. DOI: 10.1016/j.bios.2013.07.026. View